BETA


2023/2148(DEC) 2022 discharge: European Chemicals Agency (ECHA)

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead CONT SARVAMAA Petri (icon: EPP EPP) RÓNAI Sándor (icon: S&D S&D), CSEH Katalin (icon: Renew Renew), EICKHOUT Bas (icon: Verts/ALE Verts/ALE), CZARNECKI Ryszard (icon: ECR ECR), KUHS Joachim (icon: ID ID), OMARJEE Younous (icon: GUE/NGL GUE/NGL)
Committee Opinion ENVI CANFIN Pascal (icon: Renew Renew)
Lead committee dossier:

Events

2024/10/10
   Final act published in Official Journal
2024/04/11
   EP - Results of vote in Parliament
2024/04/11
   EP - Decision by Parliament
Details

The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.

Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.

Agency’s financial statements

The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.

Budgetary and financial management

Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.

The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.

Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.

Other observations

Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.

In particular, it noted that:

- the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;

- the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;

- on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);

- the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;

- the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.

Documents
2024/04/10
   EP - Debate in Parliament
2024/03/19
   EP - Committee report tabled for plenary, single reading
Documents
2024/03/19
   EP - Committee report tabled for plenary
Documents
2024/03/12
   CSL - Supplementary non-legislative basic document
Documents
2024/03/04
   EP - Vote in committee
2024/02/12
   EP - Committee opinion
Documents
2024/02/09
   EP - Amendments tabled in committee
Documents
2024/01/16
   EP - Committee draft report
Documents
2023/10/26
   CofA - Court of Auditors: opinion, report
2023/09/12
   EP - Committee referral announced in Parliament
2023/09/11
   EP - CANFIN Pascal (Renew) appointed as rapporteur in ENVI
2023/06/28
   EC - Non-legislative basic document
2023/06/28
   EC - Non-legislative basic document published
2023/06/14
   EP - SARVAMAA Petri (EPP) appointed as rapporteur in CONT

Documents

Votes

A9-0135/2024 – Petri Sarvamaa – Motion for a resolution #

2024/04/11 Outcome: +: 531, -: 48, 0: 24
DE PL ES IT FR RO CZ PT HU NL SE BE AT BG IE SK DK EL LT FI LV SI LU HR MT EE CY
Total
85
49
54
59
67
19
20
21
16
25
21
21
18
13
12
13
13
15
10
13
8
7
6
5
4
6
3
icon: PPE PPE
147

Hungary PPE

1

Denmark PPE

For (1)

1

Luxembourg PPE

2

Croatia PPE

For (1)

1

Malta PPE

For (1)

1

Estonia PPE

Against (1)

1

Cyprus PPE

For (1)

1
icon: S&D S&D
123

Czechia S&D

For (1)

1

Belgium S&D

2

Bulgaria S&D

2

Slovakia S&D

For (1)

1

Denmark S&D

2

Greece S&D

1

Lithuania S&D

2

Latvia S&D

2

Slovenia S&D

For (1)

1

Luxembourg S&D

For (1)

1

Estonia S&D

2

Cyprus S&D

1
icon: Renew Renew
93

Poland Renew

1

Hungary Renew

2
3

Austria Renew

For (1)

1

Ireland Renew

2

Slovakia Renew

3

Greece Renew

1

Lithuania Renew

1

Finland Renew

2

Latvia Renew

For (1)

1

Slovenia Renew

2

Luxembourg Renew

2

Estonia Renew

3
icon: Verts/ALE Verts/ALE
62

Poland Verts/ALE

For (1)

1

Spain Verts/ALE

3

Italy Verts/ALE

3

Czechia Verts/ALE

3

Portugal Verts/ALE

1

Netherlands Verts/ALE

1

Sweden Verts/ALE

3

Belgium Verts/ALE

3

Austria Verts/ALE

3

Ireland Verts/ALE

1

Denmark Verts/ALE

2

Greece Verts/ALE

For (1)

1

Lithuania Verts/ALE

2

Finland Verts/ALE

3

Luxembourg Verts/ALE

For (1)

1
icon: ECR ECR
61

Germany ECR

1

France ECR

For (1)

1

Sweden ECR

3

Bulgaria ECR

2

Slovakia ECR

For (1)

1

Greece ECR

1

Lithuania ECR

1

Finland ECR

Abstain (1)

2

Latvia ECR

For (1)

1

Croatia ECR

1
icon: NI NI
36

Germany NI

2

Romania NI

For (1)

1

Netherlands NI

Against (1)

1

Belgium NI

For (1)

1

Latvia NI

1
icon: The Left The Left
33

Czechia The Left

1

Portugal The Left

4

Netherlands The Left

Against (1)

1

Sweden The Left

For (1)

1

Belgium The Left

Abstain (1)

1

Denmark The Left

1

Greece The Left

1

Finland The Left

For (1)

1

Cyprus The Left

1
icon: ID ID
48

Czechia ID

Against (1)

1

Austria ID

Against (2)

2

Denmark ID

Against (1)

1
AmendmentsDossier
27 2023/2148(DEC)
2023/12/04 ENVI 15 amendments...
source: 757.144
2024/02/09 CONT 12 amendments...
source: 757.218

History

(these mark the time of scraping, not the official date of the change)

events/7
date
2024-10-10T00:00:00
type
Final act published in Official Journal
procedure/stage_reached
Old
Procedure completed, awaiting publication in Official Journal
New
Procedure completed
events/5
date
2024-04-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=61589&l=en title: Results of vote in Parliament
events/5
date
2024-04-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=61589&l=en title: Results of vote in Parliament
events/5
date
2024-04-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=61589&l=en title: Results of vote in Parliament
events/5
date
2024-04-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=61589&l=en title: Results of vote in Parliament
events/5
date
2024-04-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=61589&l=en title: Results of vote in Parliament
events/5
date
2024-04-11T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=61589&l=en title: Results of vote in Parliament
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Agency’s financial statements
  • The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.
  • Budgetary and financial management
  • Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.
  • The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.
  • Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.
  • Other observations
  • Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.
  • In particular, it noted that:
  • - the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;
  • - the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;
  • - on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);
  • - the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;
  • - the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Agency’s financial statements
  • The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.
  • Budgetary and financial management
  • Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.
  • The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.
  • Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.
  • Other observations
  • Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.
  • In particular, it noted that:
  • - the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;
  • - the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;
  • - on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);
  • - the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;
  • - the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Agency’s financial statements
  • The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.
  • Budgetary and financial management
  • Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.
  • The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.
  • Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.
  • Other observations
  • Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.
  • In particular, it noted that:
  • - the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;
  • - the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;
  • - on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);
  • - the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;
  • - the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Agency’s financial statements
  • The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.
  • Budgetary and financial management
  • Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.
  • The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.
  • Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.
  • Other observations
  • Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.
  • In particular, it noted that:
  • - the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;
  • - the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;
  • - on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);
  • - the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;
  • - the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Agency’s financial statements
  • The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.
  • Budgetary and financial management
  • Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.
  • The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.
  • Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.
  • Other observations
  • Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.
  • In particular, it noted that:
  • - the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;
  • - the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;
  • - on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);
  • - the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;
  • - the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Agency’s financial statements
  • The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.
  • Budgetary and financial management
  • Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.
  • The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.
  • Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.
  • Other observations
  • Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.
  • In particular, it noted that:
  • - the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;
  • - the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;
  • - on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);
  • - the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;
  • - the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Agency’s financial statements
  • The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.
  • Budgetary and financial management
  • Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.
  • The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.
  • Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.
  • Other observations
  • Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.
  • In particular, it noted that:
  • - the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;
  • - the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;
  • - on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);
  • - the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;
  • - the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Agency’s financial statements
  • The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.
  • Budgetary and financial management
  • Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.
  • The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.
  • Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.
  • Other observations
  • Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.
  • In particular, it noted that:
  • - the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;
  • - the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;
  • - on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);
  • - the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;
  • - the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/5/summary
  • The European Parliament decided to grant discharge to the Executive Director of the European Chemicals Agency (ECHA) for the financial year 2022 and to approve the closure of the accounts for that year.
  • Noting that the Court of Auditors has stated that it has obtained reasonable assurance that the Agency's annual accounts for the financial year 2022 are reliable and that the underlying transactions are legal and regular, Parliament adopted, by 531 votes to 48 with 24 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations contained in the resolution on the performance, financial management and control of EU agencies.
  • Agency’s financial statements
  • The Agency's final budget for the financial year 2022 was EUR 114 777 691 representing an increase of 5.83 % compared to 2021.
  • Budgetary and financial management
  • Budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98.61 %, representing a slight decrease of 0.23 % compared to 2021 and that the current year payment appropriations execution rate was 85.06 %, representing a decrease of 1.17 % in comparison to 2021.
  • The resolution called on the Commission to present the promised 2020 proposal to strengthen the governance of the Agency and increase the sustainability of its financing model.
  • Parliament noted with satisfaction that in 2022, for the first time since the final registration deadline in 2018, the Agency's fee income has increased, while reliance on the Union to finance its operations has slightly decreased.
  • Other observations
  • Parliament also made a series of observations concerning performance, staff policy, internal control and animal testing.
  • In particular, it noted that:
  • - the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still 'in progress' as planned;
  • - the Agency faced some challenges in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members;
  • - on 31 December 2022, the establishment plan was 98.07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021);
  • - the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;
  • - the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework. The phasing out process should be accelerated. The Agency is also collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals.
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/4
date
2024-04-10T00:00:00
type
Debate in Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/CRE-9-2024-04-10-TOC_EN.html title: Debate in Parliament
events/5
date
2024-04-11T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
forecasts
  • date: 2024-04-10T00:00:00 title: Indicative plenary sitting date
procedure/stage_reached
Old
Awaiting Parliament's vote
New
Procedure completed, awaiting publication in Official Journal
docs/7
date
2024-04-11T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
type
Text adopted by Parliament, single reading
body
EP
events/4
date
2024-04-10T00:00:00
type
Debate in Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/CRE-9-2024-04-10-TOC_EN.html title: Debate in Parliament
events/5
date
2024-04-11T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0258_EN.html title: T9-0258/2024
forecasts
  • date: 2024-04-10T00:00:00 title: Indicative plenary sitting date
procedure/stage_reached
Old
Awaiting Parliament's vote
New
Procedure completed, awaiting publication in Official Journal
events/4
date
2024-04-10T00:00:00
type
Debate in Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/CRE-9-2024-04-10-TOC_EN.html title: Debate in Parliament
forecasts
  • date: 2024-04-10T00:00:00 title: Indicative plenary sitting date
events/4
date
2024-04-10T00:00:00
type
Debate in Parliament
body
EP
forecasts
  • date: 2024-04-10T00:00:00 title: Indicative plenary sitting date
events/4
date
2024-04-10T00:00:00
type
Debate in Parliament
body
EP
forecasts/0
date
2024-04-11T00:00:00
title
Vote scheduled
forecasts/0
date
2024-04-10T00:00:00
title
Indicative plenary sitting date
docs/6
date
2024-03-19T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/A-9-2024-0135_EN.html title: A9-0135/2024
type
Committee report tabled for plenary, single reading
body
EP
events/3
date
2024-03-19T00:00:00
type
Committee report tabled for plenary
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/A-9-2024-0135_EN.html title: A9-0135/2024
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
docs/6
date
2024-03-19T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/A-9-2024-0135_EN.html title: A9-0135/2024
type
Committee report tabled for plenary, single reading
body
EP
events/3
date
2024-03-19T00:00:00
type
Committee report tabled for plenary
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/A-9-2024-0135_EN.html title: A9-0135/2024
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
events/3
date
2024-03-19T00:00:00
type
Committee report tabled for plenary
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
events/3
date
2024-03-19T00:00:00
type
Committee report tabled for plenary
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
events/3
date
2024-03-19T00:00:00
type
Committee report tabled for plenary
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
events/3
date
2024-03-19T00:00:00
type
Committee report tabled for plenary
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
events/3
date
2024-03-19T00:00:00
type
Committee report tabled for plenary
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
events/3
date
2024-03-19T00:00:00
type
Committee report tabled for plenary
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament's vote
docs/5
date
2024-03-12T00:00:00
docs
title: 06180/2024
type
Supplementary non-legislative basic document
body
CSL
events/2
date
2024-03-04T00:00:00
type
Vote in committee
body
EP
forecasts
  • date: 2024-04-10T00:00:00 title: Indicative plenary sitting date
docs/3
date
2024-02-06T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/ENVI-AD-754667_EN.html title: PE754.667
committee
ENVI
type
Committee opinion
body
EP
docs/4
date
2024-02-06T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/ENVI-AD-754667_EN.html title: PE754.667
committee
ENVI
type
Committee opinion
body
EP
docs/4/date
Old
2024-02-06T00:00:00
New
2024-02-12T00:00:00
docs/4
date
2024-02-09T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/CONT-AM-757218_EN.html title: PE757.218
type
Amendments tabled in committee
body
EP
docs/3/date
Old
2024-01-25T00:00:00
New
2024-02-06T00:00:00
docs/3
date
2024-01-25T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/ENVI-AD-754667_EN.html title: PE754.667
committee
ENVI
type
Committee opinion
body
EP
docs/2
date
2024-01-16T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/CONT-PR-753516_EN.html title: PE753.516
type
Committee draft report
body
EP
docs/1
date
2023-10-26T00:00:00
docs
type
Court of Auditors: opinion, report
body
CofA
commission
  • body: EC dg: Budget commissioner: HAHN Johannes
events/1
date
2023-09-12T00:00:00
type
Committee referral announced in Parliament
body
EP
procedure/dossier_of_the_committee
  • CONT/9/12932
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting committee decision
committees/1/rapporteur
  • name: CANFIN Pascal date: 2023-09-11T00:00:00 group: Renew Europe group abbr: Renew
committees/0/shadows/4
name
CZARNECKI Ryszard
group
European Conservatives and Reformists Group
abbr
ECR
committees/0
type
Responsible Committee
body
EP
committee_full
Budgetary Control
committee
CONT
associated
False
rapporteur
name: SARVAMAA Petri date: 2023-06-14T00:00:00 group: Group of European People's Party abbr: EPP
shadows
committees/0
type
Responsible Committee
body
EP
committee_full
Budgetary Control
committee
CONT
associated
False